LLY

811.14

+0.38%↑

JNJ

156.56

+0.93%↑

ABBV

192.22

+0.51%↑

NVO

81.08

+3.14%↑

UNH

318.1

+2.45%↑

LLY

811.14

+0.38%↑

JNJ

156.56

+0.93%↑

ABBV

192.22

+0.51%↑

NVO

81.08

+3.14%↑

UNH

318.1

+2.45%↑

LLY

811.14

+0.38%↑

JNJ

156.56

+0.93%↑

ABBV

192.22

+0.51%↑

NVO

81.08

+3.14%↑

UNH

318.1

+2.45%↑

LLY

811.14

+0.38%↑

JNJ

156.56

+0.93%↑

ABBV

192.22

+0.51%↑

NVO

81.08

+3.14%↑

UNH

318.1

+2.45%↑

LLY

811.14

+0.38%↑

JNJ

156.56

+0.93%↑

ABBV

192.22

+0.51%↑

NVO

81.08

+3.14%↑

UNH

318.1

+2.45%↑

Search

AcelRx Pharmaceuticals Inc

Gesloten

0

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

Max

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+532.91% upside

AcelRx Pharmaceuticals Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

12 jun 2025, 20:41 UTC

Winsten

Adobe Raises Outlook After 2Q Sales Beat

12 jun 2025, 23:50 UTC

Winsten

Adobe Keeps Pivoting as AI Transforms Customer Needs -- Update

12 jun 2025, 23:50 UTC

Winsten

Adobe Customer Demand Shifting Toward Idea Generation, CFO Says

12 jun 2025, 23:50 UTC

Winsten

Adobe FireFly Products Drove Revenue Beat in 2Q, CFO Says

12 jun 2025, 23:48 UTC

Marktinformatie

Gold Steady Amid Geopolitical Risks -- Market Talk

12 jun 2025, 23:45 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

12 jun 2025, 23:45 UTC

Marktinformatie

Nikkei May Trade Rangebound Amid Tariff Uncertainty -- Market Talk

12 jun 2025, 21:26 UTC

Winsten

Friedman Industries 4Q Sales $129.2M >FRD

12 jun 2025, 21:25 UTC

Winsten

Friedman Industries 4Q EPS 76c >FRD

12 jun 2025, 21:11 UTC

Winsten

Adobe Beat Estimates and Raises Revenue Guidance -- Barrons.com

12 jun 2025, 20:50 UTC

Marktinformatie
Winsten

Tech, Media & Telecom Roundup: Market Talk

12 jun 2025, 20:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

12 jun 2025, 20:31 UTC

Winsten

Adobe Beat Estimates and Raises Revenue Guidance -- Barrons.com

12 jun 2025, 20:30 UTC

Winsten
Acquisities, Fusies, Overnames

Chime IPO: Stock Soars in Nasdaq Debut, Valuing It at Nearly $14 Billion -- Barrons.com

12 jun 2025, 20:15 UTC

Winsten

Adobe Sees FY25 Rev $23.5B-$23.6B >ADBE

12 jun 2025, 20:15 UTC

Winsten

Adobe Sees 3Q Rev $5.88B-$5.93B >ADBE

12 jun 2025, 20:14 UTC

Winsten

Adobe Stock Pops as Earnings Beat Estimates -- Barrons.com

12 jun 2025, 20:07 UTC

Winsten

Adobe Raises FY25 Rev and EPS Targets

12 jun 2025, 20:05 UTC

Winsten

Adobe Sees FY Adj EPS $20.50-Adj EPS $20.70 >ADBE

12 jun 2025, 20:05 UTC

Winsten

Adobe 2Q Digital Experience Revenue $1.46B >ADBE

12 jun 2025, 20:05 UTC

Winsten

Adobe 2Q Digital Media Revenue $4.35B >ADBE

12 jun 2025, 20:05 UTC

Winsten

Adobe Sees 3Q EPS $4.00-EPS $4.05 >ADBE

12 jun 2025, 20:05 UTC

Winsten

Adobe 2Q Net $1.69B >ADBE

12 jun 2025, 20:05 UTC

Winsten

Adobe 2Q EPS $3.94 >ADBE

12 jun 2025, 20:05 UTC

Winsten

Adobe 2Q Digital Experience Revenue Up 10% >ADBE

12 jun 2025, 20:05 UTC

Winsten

Adobe 2Q Rev $5.87B >ADBE

12 jun 2025, 20:05 UTC

Winsten

Adobe Sees 3Q Adj EPS $5.15-Adj EPS $5.20 >ADBE

12 jun 2025, 20:05 UTC

Winsten

Adobe Sees FY EPS $16.30-EPS $16.50 >ADBE

12 jun 2025, 20:05 UTC

Winsten

Adobe 2Q Digital Media Revenue Up 11% >ADBE

12 jun 2025, 20:05 UTC

Winsten

Adobe 2Q Adj EPS $5.06 >ADBE

Peer Vergelijking

Prijswijziging

AcelRx Pharmaceuticals Inc Prognose

Koersdoel

By TipRanks

532.91% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 5 USD  532.91%

Hoogste 5 USD

Laagste 5 USD

Gebaseerd op 1 Wall Street-analisten die 12-maands prijsdoelen bieden voor AcelRx Pharmaceuticals Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

1 ratings

1

Buy

0

Hold

0

Sell

Financieel

$